Vergent Bioscience, Inc. — Form D/A

Vergent Bioscience, Inc. of MINNEAPOLIS, MN, a company, filed a Form D amendment with the SEC on 2019-02-22. The offering totals $9.7M, of which $9.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Douglas KohrsDirectorDALLAS, TX
Ryan EgelandDirectorMaple Grove, MN
Bobby T HelmedagDirectorMinneapolis, MN
Jeffrey T YureckoExecutive OfficerMinneapolis, MN
Anita T WatkinsDirectorMinneapolis, MN
John T Santini, Jr.DirectorMinneapolis, MN
John T Santini, Jr.Executive OfficerMinneapolis, MN
Raymond T WongDirectorMinneapolis, MN
Douglas T KohrsDirectorMinneapolis, MN
Jeff JulkowskiDirectorMinneapolis, MN
Raymond WongDirectorHong Kong, K3
Jeffrey YureckoExecutive OfficerMinneapolis, MN
John SantiniDirectorMinneapolis, MN
John SantiniExecutive OfficerMinneapolis, MN
Anita WatkinsDirectorMinneapolis, MN
Samuel Dean BanksDirectorMinneapolis, MN
Anita WilsonDirectorMinneapolis, MN
Samuel BanksDirectorToronto, A6
Margo ShoupDirectorMINNEAPOLIS, MN
Jeffrey JulkowskiDirectorMINNEAPOLIS, MN
Jeffrey JulkowskiPromoterMINNEAPOLIS, MN
Raymond Dean WongDirectorMINNEAPOLIS, MN
Ryan Dean EgelandDirectorMINNEAPOLIS, MN
Samuel Dean BanksDirectorMINNEAPOLIS, MN
Douglas Dean KohrsDirectorMINNEAPOLIS, MN

Other filings by this issuer (7)

FiledFormOfferingSold
2025-10-20D$32.0M$18.7M
2025-02-18D$5.0M$3.8M
2025-02-18D/A$5.0M$3.8M
2022-10-04D$22.1M$21.5M
2021-11-22D$2.0M$1.2M
2020-09-23D/A$11.9M$11.9M
2018-06-01D$8.7M$8.7M

More